AMPH Amphastar Pharmaceuticals
- 44.220
- -0.420-0.94%
- 44.500
- +0.280+0.63%
Amphastar Pharmaceuticals News
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhou Rong
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PRINS RICHARD K
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Jack Y.
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Liawatidewi Yakob
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer PETERS WILLIAM J
Amphastar Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | 8-K: Current report
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhou Rong
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhang Jack Y.
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Petersen Floyd F.
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | 8-K: Current report
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Zhou Rong
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director PRINS RICHARD K
Amphastar Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Amphastar Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Analysis
Price Target
No Data
No Data
